Skip to main content
Ethan Lerner, MD, Dermatology, Charlestown, MA

EthanALernerMDPhD

Dermatology Charlestown, MA

Associate Professor of Dermatology, Massachusetts General Hospital

Dr. Lerner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lerner's full profile

Already have an account?

  • Office

    Mass. General Hosp -East
    Building 149, 13th St.
    Charlestown, MA 02129
    Phone+1 617-726-4439

Education & Training

  • Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1984 - 1987
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1982 - 1984
  • Yale School of Medicine
    Yale School of MedicineClass of 1982

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1984 - 2025
  • ME State Medical License
    ME State Medical License Active through 1990
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Lectures

  • Chronic Pruritus: Bedside to Bench Perspectives 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
  • 7th World Congress on ITCH 
    International Forum for the Study of Itch, Boston, Massachusetts - 9/21/2013

Press Mentions

  • Prominent Investigators Receive NEA Grants Targeting Eczema Research: Over 30m Underserved Patients in USA Alone
    Prominent Investigators Receive NEA Grants Targeting Eczema Research: Over 30m Underserved Patients in USA AloneDecember 23rd, 2020
  • Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical Needs
    Escient Pharmaceuticals Launches with $40 Million Series A Financing to Advance First-in-Class G Protein-Coupled Receptor (GPCR)-Targeted Drugs to Address Serious, Unserved Medical NeedsMay 9th, 2018
  • Pick the Right Products to Stop Itchy Skin
    Pick the Right Products to Stop Itchy SkinAugust 5th, 2017
  • Join now to see all

Grant Support

  • Itch, Proteases And Protease-Activated ReceptorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
  • G-Protein Coupled Receptors For Bioagent DetectionNational Institute Of Allergy And Infectious Diseases2004–2006
  • Cutaneous Biology Of Nitric OxideNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
  • Maxadilan, A Cutaneous Vasodilator From Sand FliesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–2002

Professional Memberships